Jefferies initiated a "buy" rating on Rocket Pharmaceuticals, based on the biotech firm's experimental gene therapies.
Gerdau S/A Ord-3.76% R$41.2B ...
S&P/TSX Composite Index 24,557.00-562.71-2.24% ...
Asian shares struggled for direction after Wall Street edged lower, with traders bracing for the Federal Reserve’s final policy decision of the year. Equities slipped in Japan in early trade while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback